In recent years, advances with topical therapies have produced new ways to deliver these creams and ointments.
-This includes sprays and foams and shampoos, as well as more advanced gels and ointments. Many of these treat larger or more sensitive areas more easily, effectively, and safely.
-Phototherapy is now available in a more focused form called narrow-band ultraviolet B (UVB) therapy. This lessens the risk of skin cancer.
- Anti-tumor necrosis factor (anti-TNF) drugs are one type of biologic now used for psoriasis. These were first developed as treatment for rheumatoid arthritis, says Heffernan. But TNF is a protein also involved in the development of psoriasis and psoriatic arthritis.
Examples of anti-TNF drugs are:
Adalimumab (Humira), approved for psoriasis and psoriatic arthritis
Etanercept (Enbrel), approved for psoriasis and psoriatic arthritis
Golimumab (Simponi), approved for psoriatic arthritis
Infliximab (Remicade), approved for psoriasis and psoriatic arthritis
- As researchers better understand how the immune system works with psoriasis, they have developed biologics specifically for this disease. Such as:
Ustekinumab (Stelara) targets two proteins, interleukin-12 and interleukin-23, that help regulate the immune system. Researchers believe these proteins promote inflammation linked specifically to psoriasis.
-This includes sprays and foams and shampoos, as well as more advanced gels and ointments. Many of these treat larger or more sensitive areas more easily, effectively, and safely.
-Phototherapy is now available in a more focused form called narrow-band ultraviolet B (UVB) therapy. This lessens the risk of skin cancer.
- Anti-tumor necrosis factor (anti-TNF) drugs are one type of biologic now used for psoriasis. These were first developed as treatment for rheumatoid arthritis, says Heffernan. But TNF is a protein also involved in the development of psoriasis and psoriatic arthritis.
Examples of anti-TNF drugs are:
Adalimumab (Humira), approved for psoriasis and psoriatic arthritis
Etanercept (Enbrel), approved for psoriasis and psoriatic arthritis
Golimumab (Simponi), approved for psoriatic arthritis
Infliximab (Remicade), approved for psoriasis and psoriatic arthritis
- As researchers better understand how the immune system works with psoriasis, they have developed biologics specifically for this disease. Such as:
Ustekinumab (Stelara) targets two proteins, interleukin-12 and interleukin-23, that help regulate the immune system. Researchers believe these proteins promote inflammation linked specifically to psoriasis.
•
the recent drugs are biologic especially anti tumor necrotic factor tnf wich improve psoriasis and psoriatic arthritis like infliximab also important is phototherapy with uvb
•
